نمایش پرونده ساده آیتم

dc.contributor.authorBabri, S
dc.contributor.authorMohaddes, G
dc.contributor.authorFeizi, I
dc.contributor.authorMohammadnia, A
dc.contributor.authorNiapour, A
dc.contributor.authorAlihemmati, A
dc.contributor.authorAmani, M
dc.date.accessioned2018-08-26T08:52:50Z
dc.date.available2018-08-26T08:52:50Z
dc.date.issued2014
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53816
dc.description.abstractAlzheimers disease (AD) is a neurodegenerative disorder with a progressive cognitive decline and memory loss. Multiple pathogenetic factors including aggregated ?-amyloid (A?), neurofibrillary tangles (NFTs), cholinergic dysfunction and oxidative stress are involved in AD. A?, a major constituent of the senile plaques, is a potent neurotoxic peptide and has a pivotal role in cognitive deficit and reduced synaptic plasticity in AD. In the present study we examined the protective effect of troxerutin, as a multipotent bioflavonoid, on A? (1-42)-induced impairment of evoked field potential in hippocampal DG neurons. Male Wistar rats were divided into four groups including A? (42-1), A? (1-42), A? (1-42) plus troxerutin and A? (42-1) plus troxerutin groups. A? was injected intracerebroventricularly (i.c.v.) into right lateral ventricle and after two weeks the evoked field potential recorded from perforant path-DG synapses to assess paired pulse paradigm and long term potentiation (LTP). Administration of A? (1-42) drastically attenuated the LTP of DG neurons, while there was no significant difference in evoked field potentials between A? (1-42) plus troxerutin group with respect to A? (42-1) group. This study revealed that troxerutin improves the synaptic failure induced by A? peptide and can be introduced as a promising multi-potent pharmacological agent in prevention or treatment of AD in the future. © 2014 Elsevier B.V.
dc.language.isoEnglish
dc.relation.ispartofEuropean Journal of Pharmacology
dc.subjecttroxerutin
dc.subjectamyloid beta protein
dc.subjectmonoxerutin
dc.subjectneuroprotective agent
dc.subjecttroxerutin
dc.subjectAlzheimer disease
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectarticle
dc.subjectbrain nerve cell
dc.subjectcontrolled study
dc.subjectdentate gyrus
dc.subjectdrug effect
dc.subjectdrug mechanism
dc.subjectdrug structure
dc.subjectlong term potentiation
dc.subjectmale
dc.subjectnerve cell plasticity
dc.subjectnerve potential
dc.subjectneuroprotection
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectrat
dc.subjectAlzheimer disease
dc.subjectanalogs and derivatives
dc.subjectanimal
dc.subjectchemically induced
dc.subjectdrug effects
dc.subjectelectrophysiology
dc.subjectmaze test
dc.subjectMemory Disorders
dc.subjectpathology
dc.subjectpsychology
dc.subjectsynapse
dc.subjectWistar rat
dc.subjectAlzheimer Disease
dc.subjectAmyloid beta-Peptides
dc.subjectAnimals
dc.subjectDentate Gyrus
dc.subjectElectrophysiological Processes
dc.subjectHydroxyethylrutoside
dc.subjectLong-Term Potentiation
dc.subjectMale
dc.subjectMaze Learning
dc.subjectMemory Disorders
dc.subjectNeuronal Plasticity
dc.subjectNeuroprotective Agents
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectSynapses
dc.titleEffect of troxerutin on synaptic plasticity of hippocampal dentate gyrus neurons in a ?-amyloid model of Alzheimers disease: An electrophysiological study
dc.typeArticle
dc.citation.volume732
dc.citation.issue1
dc.citation.spage19
dc.citation.epage25
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1016/j.ejphar.2014.03.018


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم